VikramKhuranaMDPhD

Summary

• Vik Khurana is on the faculty at Harvard Medical School and Brigham and Women's Hospital, and a scientific co-Founder of Yumanity Therapeutics. His clinical and research interests relate to neurodegenerative movement disorders, including Parkinson's disease, multiple system atrophy and the cerebellar ataxias. He is a medical graduate of the University of Sydney, Australia, and came to Boston as a Fulbright Scholar and Merck Company Foundation Fellow in 2001, obtaining his Ph.D. in neurobiology from Harvard University in 2006. He completed his residency in Neurology at Brigham and Women's and Massachusetts General Hospitals, and Fellowship training in Movement Disorders and Ataxia at Massachusetts General Hospital. He was a postdoctoral Fellow at the Whitehead Institute/MIT with Susan Lindquist and Rudolf Jaenisch. His research efforts aim to develop novel therapies for neurodegenerative diseases by using diverse model systems including patient-derived stem cells. This work has been supported by funding from the Howard Hughes Medical Institute, the JPB Foundation, and awards from foundations including the American Brain Foundation,Parkinson's Disease Foundations and Multiple System Atrophy coalition . Vik is a member of the Global Multiple System Atrophy Roadmap Consortium and sits on the Board of the MSA Coalition. His recent research has been published in leading journals, including Science, Cell Systems and Cell.